Otsuka (OTCMKTS:OTSKY) Issues FY 2025 Earnings Guidance

Otsuka (OTCMKTS:OTSKY) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided EPS guidance of 3.360-3.360 for the period. The company issued revenue guidance of $15.6 billion-$15.6 billion.

Otsuka Trading Up 3.3 %

Shares of OTCMKTS:OTSKY traded up $0.86 during mid-day trading on Friday, reaching $26.48. The company had a trading volume of 37,745 shares, compared to its average volume of 44,546. The company’s 50-day moving average price is $26.78 and its 200-day moving average price is $28.02. Otsuka has a one year low of $17.74 and a one year high of $32.41.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.